Gregory A. Yanik - Concepedia

Author

Gregory A. Yanik

Also Known As

Anne Bergeron, G A Yanik, G Yanik, G. Yanik, G.A. Yanik, GREGORY YANIK, Gregory A Yanik, Gregory A. Yanik, Gregory Anthony Yanik, Gregory Yanik

330

Publications

15.6K

Citations

H-Index

102

Concepts

All Affiliations

University of Michigan Children's Hospital of Philadelphia Children's Hospital of Los Angeles University of Pennsylvania University of California, San Francisco

About

Gregory A. Yanik is an author at University of Michigan specializing in medicine, immunology, and transplantation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	40	2.1K
2	Health Sciences	10	10	530
3	Education	1	1	32
4	Engineering	1	1	17
5	African American Studies	1	1	32

Gregory A. Yanik

122

Publications

14.1K

Citations

H-Index

Page 1

	Year	Citations
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia Shannon L. Maude, Theodore W. Laetsch, Jochen Buechner, New England Journal of Medicine	2018	5.4K
Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation Éliane Gluckman, Barbara Cappelli, Françoise Bernaudin, Blood	2016	454
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth Rajen Mody, Yi-Mi Wu, Robert J. Lonigro, JAMA	2015	408
Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression. James D. Geiger, Raymond J. Hutchinson, Lyndon Hohenkirk, PubMed ImmunologySpecific T CellsPathologyImmunotherapyTumor Immunology	2001	323
Three-Year Update of Tisagenlecleucel in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia in the ELIANA Trial Theodore W. Laetsch, Shannon L. Maude, Susana Rives, Journal of Clinical Oncology	2022	314
Phase II Study on the Effect of Disease Sites, Age, and Prior Therapy on Response to Iodine-131-Metaiodobenzylguanidine Therapy in Refractory Neuroblastoma Katherine K. Matthay, Gregory A. Yanik, Julia A. Messina, Journal of Clinical Oncology	2007	257
Elafin Is a Biomarker of Graft-Versus-Host Disease of the Skin Sophie Paczesny, Thomas Braun, John E. Levine, Science Translational Medicine ImmunologyPathologySkin GvhdGvhd Skin BiopsiesDermatology	2010	241
Phase II Trial of Costimulation Blockade With Abatacept for Prevention of Acute GVHD Benjamin Watkins, Muna Qayed, Courtney McCracken, Journal of Clinical Oncology	2021	234
An early-biomarker algorithm predicts lethal graft-versus-host disease and survival Matthew J. Hartwell, Umut Özbek, Ernst Holler, JCI Insight	2017	218
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology Patrick A. Brown, Hiroto Inaba, Colleen Annesley, Journal of the National Comprehensive Cancer Network Hematological MalignancyTranslational MedicineOncologyTransplantationPediatric Hematology	2020	204

Page 1